Secure Today's Low Prices Before They Rise Further
Current Mounjaro Pricing - Beat the Increases
With pharmaceutical costs rising across the UK, EverydayMeds maintains the market's most competitive Mounjaro pricing. Our prescription-only tirzepatide supply starts from just £129.99 for 2.5mg pens (first order) compared to significantly higher prices elsewhere. Single pen pricing includes 5mg at £159.99, 7.5mg at £209.99, and 10mg at £229.99 for new customers, with returning patient discounts of £25 off every order.
Bundle Savings - Maximum Value
Our bundle options deliver exceptional value as costs rise industry-wide. The Intro Duo (2.5mg + 5mg) costs just £299.99 for first orders, saving considerably versus individual purchases. Progress Duo combinations (5mg + 7.5mg) at £369.99 first order provide seamless dose progression. Three-pen bundles offer even greater savings, with the Intro Trio at £534.99 representing outstanding value for your complete treatment journey.
Why Prices May Increase Soon
Pharmaceutical supply chains face ongoing pressures from manufacturing costs, regulatory changes, and currency fluctuations. Many suppliers have already implemented price increases, making EverydayMeds' current rates increasingly valuable. Our GPhC-registered pharmacy absorbs many cost pressures to maintain accessible pricing, but market forces suggest industry-wide increases are inevitable.
Lock In Today's Rates
Secure your Mounjaro prescription at current low prices through our streamlined ordering process. Clinical assessment approval takes just 3 working days standard, or upgrade to express 24-hour processing. This prescription-only medication requires professional evaluation, but our experienced clinicians provide rapid, thorough assessments to get your treatment started quickly.
Genuine Medication, Unbeatable Service
Every Mounjaro pen comes direct from licensed pharmaceutical suppliers to our GPhC-registered facility. This tirzepatide injection activates GIP and GLP-1 hormones that may help regulate appetite and promote feelings of fullness when used alongside reduced-calorie diet and increased physical activity. MHRA additional monitoring ensures the highest safety standards for this prescription-only treatment.
